Orbimed Advisors LLC’s Dyne Therapeutics Inc Position
Does Orbimed Advisors LLC own Dyne Therapeutics Inc (DYN)? Yes — 2.92M shares worth $53M (+1.05% of its 13F portfolio) as of Q1 2026, up from 2.20M shares the prior filed quarter.
Position Value
$53M
Q1 2026
Shares
2.92M
% of Portfolio
+1.05%
Quarters Held
14
currently held
Position History DYN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 2.92M | $53M | +1.05% |
| Q4 2025 | 2.20M | $43M | +0.88% |
| Q3 2025 | 2.31M | $29M | +0.69% |
| Q2 2025 | 1.03M | $10M | +0.25% |
| Q1 2025 | 1.01M | $11M | +0.25% |
| Q4 2024 | 1.23M | $29M | +0.59% |
| Q3 2024 | 708.4K | $25M | +0.46% |
| Q2 2024 | 708.4K | $25M | +0.49% |
| Q1 2024 | 708.4K | $20M | +0.37% |
| Q3 2022 | 220.4K | $3M | +0.05% |
| Q2 2021 | 350.0K | $7M | +0.07% |
| Q1 2021 | 350.0K | $5M | +0.05% |
| Q4 2020 | 350.0K | $7M | +0.06% |
| Q3 2020 | 350.0K | $7M | +0.09% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of DYN.